Main, Apolinario L.
HRN: 21-73-60 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/03/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
03/03/2023
03/07/2023
IVT
500mg
Q6
Acute Ruptured Appendicitis With Localized Peritonitis, S/p EL, AP, Lavage
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes